Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma

Dario Barbone, Loes Van Dam, Carlo Follo, Puthen V. Jithesh, Shu Dong Zhang, William G. Richards, Raphael Bueno, Dean A. Fennell, V. Courtney Broaddus

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To investigate the underlying causes of chemoresistance in malignant pleural mesothelioma, we have studied mesothelioma cell lines as 3D spheroids, which acquire increased chemoresistance compared to 2D monolayers. We asked whether the gene expression of 3D spheroids would reveal mechanisms of resistance. To address this, we measured gene expression of three mesothelioma cell lines, M28, REN and VAMT, grown as 2D monolayers and 3D spheroids. A total of 209 genes were differentially expressed in common by the three cell lines in 3D (138 upregulated and 71 downregulated), although a clear resistance pathway was not apparent. We then compared the list of 3D genes with two publicly available datasets of gene expression of 56 pleural mesotheliomas compared to normal tissues. Interestingly, only three genes were increased in both 3D spheroids and human tumors: argininosuccinate synthase 1(ASS1), annexin A4 (ANXA4) and major vault protein (MVP); of these, ASS1 was the only consistently upregulated of the three genes by qRT-PCR. To measure ASS1 protein expression, we stained 2 sets of tissue microarrays (TMA): one with 88 pleural mesothelioma samples and the other with additional 88 pleural mesotheliomas paired with matched normal tissues. Of the 176 tumors represented on the two TMAs, ASS1 was expressed in 87 (50%; staining greater than 1 up to 3+). For the paired samples, ASS1 expression in mesothelioma was significantly greater than in the normal tissues. Reduction of ASS1 expression by siRNA significantly sensitized mesothelioma spheroids to the pro-apoptotic effects of bortezomib and of cisplatin plus pemetrexed. Although mesothelioma is considered by many to be an ASS1-deficient tumor, our results show that ASS1 is elevated at the mRNA and protein levels in mesothelioma 3D spheroids and in human pleural mesotheliomas. We also have uncovered a survival role for ASS1, which may be amenable to targeting to undermine mesothelioma multicellular resistance

Original languageEnglish
Article numbere0150044
JournalPLoS One
Volume11
Issue number3
DOIs
Publication statusPublished - 16 Mar 2016

Fingerprint

Argininosuccinate Synthase
mesothelioma
Mesothelioma
Gene expression
Gene Expression
gene expression
Genes
Tissue
Tumors
Cells
Pemetrexed
Monolayers
cell lines
Cell Line
neoplasms
Annexins
genes
Microarrays
Neoplasms
Small Interfering RNA

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Barbone, D., Van Dam, L., Follo, C., Jithesh, P. V., Zhang, S. D., Richards, W. G., ... Broaddus, V. C. (2016). Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma. PLoS One, 11(3), [e0150044]. https://doi.org/10.1371/journal.pone.0150044

Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma. / Barbone, Dario; Van Dam, Loes; Follo, Carlo; Jithesh, Puthen V.; Zhang, Shu Dong; Richards, William G.; Bueno, Raphael; Fennell, Dean A.; Broaddus, V. Courtney.

In: PLoS One, Vol. 11, No. 3, e0150044, 16.03.2016.

Research output: Contribution to journalArticle

Barbone, D, Van Dam, L, Follo, C, Jithesh, PV, Zhang, SD, Richards, WG, Bueno, R, Fennell, DA & Broaddus, VC 2016, 'Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma', PLoS One, vol. 11, no. 3, e0150044. https://doi.org/10.1371/journal.pone.0150044
Barbone, Dario ; Van Dam, Loes ; Follo, Carlo ; Jithesh, Puthen V. ; Zhang, Shu Dong ; Richards, William G. ; Bueno, Raphael ; Fennell, Dean A. ; Broaddus, V. Courtney. / Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma. In: PLoS One. 2016 ; Vol. 11, No. 3.
@article{eec890b735994be482cd25a9c0fd1842,
title = "Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma",
abstract = "To investigate the underlying causes of chemoresistance in malignant pleural mesothelioma, we have studied mesothelioma cell lines as 3D spheroids, which acquire increased chemoresistance compared to 2D monolayers. We asked whether the gene expression of 3D spheroids would reveal mechanisms of resistance. To address this, we measured gene expression of three mesothelioma cell lines, M28, REN and VAMT, grown as 2D monolayers and 3D spheroids. A total of 209 genes were differentially expressed in common by the three cell lines in 3D (138 upregulated and 71 downregulated), although a clear resistance pathway was not apparent. We then compared the list of 3D genes with two publicly available datasets of gene expression of 56 pleural mesotheliomas compared to normal tissues. Interestingly, only three genes were increased in both 3D spheroids and human tumors: argininosuccinate synthase 1(ASS1), annexin A4 (ANXA4) and major vault protein (MVP); of these, ASS1 was the only consistently upregulated of the three genes by qRT-PCR. To measure ASS1 protein expression, we stained 2 sets of tissue microarrays (TMA): one with 88 pleural mesothelioma samples and the other with additional 88 pleural mesotheliomas paired with matched normal tissues. Of the 176 tumors represented on the two TMAs, ASS1 was expressed in 87 (50{\%}; staining greater than 1 up to 3+). For the paired samples, ASS1 expression in mesothelioma was significantly greater than in the normal tissues. Reduction of ASS1 expression by siRNA significantly sensitized mesothelioma spheroids to the pro-apoptotic effects of bortezomib and of cisplatin plus pemetrexed. Although mesothelioma is considered by many to be an ASS1-deficient tumor, our results show that ASS1 is elevated at the mRNA and protein levels in mesothelioma 3D spheroids and in human pleural mesotheliomas. We also have uncovered a survival role for ASS1, which may be amenable to targeting to undermine mesothelioma multicellular resistance",
author = "Dario Barbone and {Van Dam}, Loes and Carlo Follo and Jithesh, {Puthen V.} and Zhang, {Shu Dong} and Richards, {William G.} and Raphael Bueno and Fennell, {Dean A.} and Broaddus, {V. Courtney}",
year = "2016",
month = "3",
day = "16",
doi = "10.1371/journal.pone.0150044",
language = "English",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma

AU - Barbone, Dario

AU - Van Dam, Loes

AU - Follo, Carlo

AU - Jithesh, Puthen V.

AU - Zhang, Shu Dong

AU - Richards, William G.

AU - Bueno, Raphael

AU - Fennell, Dean A.

AU - Broaddus, V. Courtney

PY - 2016/3/16

Y1 - 2016/3/16

N2 - To investigate the underlying causes of chemoresistance in malignant pleural mesothelioma, we have studied mesothelioma cell lines as 3D spheroids, which acquire increased chemoresistance compared to 2D monolayers. We asked whether the gene expression of 3D spheroids would reveal mechanisms of resistance. To address this, we measured gene expression of three mesothelioma cell lines, M28, REN and VAMT, grown as 2D monolayers and 3D spheroids. A total of 209 genes were differentially expressed in common by the three cell lines in 3D (138 upregulated and 71 downregulated), although a clear resistance pathway was not apparent. We then compared the list of 3D genes with two publicly available datasets of gene expression of 56 pleural mesotheliomas compared to normal tissues. Interestingly, only three genes were increased in both 3D spheroids and human tumors: argininosuccinate synthase 1(ASS1), annexin A4 (ANXA4) and major vault protein (MVP); of these, ASS1 was the only consistently upregulated of the three genes by qRT-PCR. To measure ASS1 protein expression, we stained 2 sets of tissue microarrays (TMA): one with 88 pleural mesothelioma samples and the other with additional 88 pleural mesotheliomas paired with matched normal tissues. Of the 176 tumors represented on the two TMAs, ASS1 was expressed in 87 (50%; staining greater than 1 up to 3+). For the paired samples, ASS1 expression in mesothelioma was significantly greater than in the normal tissues. Reduction of ASS1 expression by siRNA significantly sensitized mesothelioma spheroids to the pro-apoptotic effects of bortezomib and of cisplatin plus pemetrexed. Although mesothelioma is considered by many to be an ASS1-deficient tumor, our results show that ASS1 is elevated at the mRNA and protein levels in mesothelioma 3D spheroids and in human pleural mesotheliomas. We also have uncovered a survival role for ASS1, which may be amenable to targeting to undermine mesothelioma multicellular resistance

AB - To investigate the underlying causes of chemoresistance in malignant pleural mesothelioma, we have studied mesothelioma cell lines as 3D spheroids, which acquire increased chemoresistance compared to 2D monolayers. We asked whether the gene expression of 3D spheroids would reveal mechanisms of resistance. To address this, we measured gene expression of three mesothelioma cell lines, M28, REN and VAMT, grown as 2D monolayers and 3D spheroids. A total of 209 genes were differentially expressed in common by the three cell lines in 3D (138 upregulated and 71 downregulated), although a clear resistance pathway was not apparent. We then compared the list of 3D genes with two publicly available datasets of gene expression of 56 pleural mesotheliomas compared to normal tissues. Interestingly, only three genes were increased in both 3D spheroids and human tumors: argininosuccinate synthase 1(ASS1), annexin A4 (ANXA4) and major vault protein (MVP); of these, ASS1 was the only consistently upregulated of the three genes by qRT-PCR. To measure ASS1 protein expression, we stained 2 sets of tissue microarrays (TMA): one with 88 pleural mesothelioma samples and the other with additional 88 pleural mesotheliomas paired with matched normal tissues. Of the 176 tumors represented on the two TMAs, ASS1 was expressed in 87 (50%; staining greater than 1 up to 3+). For the paired samples, ASS1 expression in mesothelioma was significantly greater than in the normal tissues. Reduction of ASS1 expression by siRNA significantly sensitized mesothelioma spheroids to the pro-apoptotic effects of bortezomib and of cisplatin plus pemetrexed. Although mesothelioma is considered by many to be an ASS1-deficient tumor, our results show that ASS1 is elevated at the mRNA and protein levels in mesothelioma 3D spheroids and in human pleural mesotheliomas. We also have uncovered a survival role for ASS1, which may be amenable to targeting to undermine mesothelioma multicellular resistance

UR - http://www.scopus.com/inward/record.url?scp=85014577074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014577074&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0150044

DO - 10.1371/journal.pone.0150044

M3 - Article

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0150044

ER -